TLR7 expression and TLR7 rs3853839 (C/G) genotyping can be useful biomarkers in SLE and other autoimmune diseases to help identify patients who might respond well to TLR7 and/or IFN blockade or B cell-targeted therapies. The gene discussed is IFNA1; the disease is autoimmune disease.